Federated Hermes, Inc. Horizon Therapeutics Public LTD CO Transaction History

Federated Hermes, Inc.

$42.5 Billion
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$62.39 - $113.8 $5.56 Million - $10.1 Million	-89,181 Reduced 48.17%	95,953 $10.9 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $5.5 Million - $7.9 Million	-93,333 Reduced 33.52%	185,134 $11.5 Million
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $1.53 Million - $2.25 Million	-19,328 Reduced 6.49%	278,467 $22.2 Million
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $1.04 Million - $1.32 Million	12,011 Added 4.2%	297,795 $31.3 Million
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $301,593 - $366,924	3,060 Added 1.08%	285,784 $30.8 Million

Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $7.07 Million - $8.49 Million	-76,938 Reduced 21.39%	282,724 $31 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $48,984 - $54,482	568 Added 0.16%	359,662 $33.7 Million
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $10 Million - $13.4 Million	-139,894 Reduced 28.04%	359,094 $33.1 Million
Q4 2020 Feb 12, 2021	SELL	$67.0 - $84.39 $1.4 Million - $1.76 Million	-20,893 Reduced 4.02%	498,988 $36.5 Million
Q3 2020 Nov 12, 2020	BUY	$55.23 - $79.93 $340,713 - $493,088	6,169 Added 1.2%	519,881 $40.4 Million
Q2 2020 Aug 13, 2020	BUY	$30.2 - $56.98 $11 Million - $20.8 Million	365,846 Added 247.42%	513,712 $28.6 Million
Q1 2020 May 13, 2020	SELL	$24.87 - $38.56 $5.12 Million - $7.93 Million	-205,777 Reduced 58.19%	147,866 $4.38 Million
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $767,680 - $1.11 Million	-30,188 Reduced 7.86%	353,643 $12.8 Million
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $6.04 Million - $7.34 Million	-262,461 Reduced 40.61%	383,831 $10.5 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $14.7 Million - $18.4 Million	646,292 New	646,292 $15.6 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account